Sobi to Acquire CTI BioPharma ...Middle East

Transaction Price of $9.10 Per Share Represents Compelling 89% Premium to CTI's Closing Stock Price on May 9, 2023 SEATTLE, May 10, 2023 /PRNewswire/ -- CTI BioPharma (Nasdaq: CTIC) ("CTI"), a commercial biopharmaceutical company focused on the development and commercialization of novel...

Hence then, the article about sobi to acquire cti biopharma was published today ( Wednesday 10/05/2023 - 08:12 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Sobi to Acquire CTI BioPharma )

Also on site :

• Aldi's 3-Piece Vintage-Inspired Apothecary Jar Set Will Elevate Your Bathroom Organization Beautifully
• Russia-Ukraine war: List of key events, day 1,433
• Maria Shriver Sends a Clear Message About America's Future: 'No More Excuses'